ArticleOncology letters2024

Hypopituitarism induced by pembrolizumab plus axitinib in the treatment of metastatic renal cell carcinoma: A case report.

Kazushi Hanawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.